Aptar Radolfzell Gmbh – FDA 483, Feb 25, 2022
Aptar Radolfzell Gmbh, a sterile drug container closure manufacturer in Riegel-Engen, Germany, received a Form 483 for significant quality system deficiencies. The inspection revealed failures in thoroughly investigating discrepancies and out-of-specification results, a lack of written procedures for production and process controls, and inadequate design verification for their Ophthalmic Squeeze Dispenser (OSD) product. These observations indicate a need for improved quality oversight in manufacturing and design processes.
ID · fd9548d3-91de-4c9e-9bac-0e8369f8d9c6
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.